Stockscreener 앱 받기
0.2913
10.40%
-0.0338
전일 마감가:
$0.3251
열려 있는:
$0.323
하루 거래량:
1.65M
Relative Volume:
0.27
시가총액:
$12.10M
수익:
$7.33M
순이익/손실:
$-21.20M
주가수익비율:
-0.3186
EPS:
-0.9143
순현금흐름:
$-12.68M
1주 성능:
-24.44%
1개월 성능:
-47.94%
6개월 성능:
-11.91%
1년 성능:
-86.70%
1일 변동 폭
$0.2884
$0.323
1주일 범위
$0.2884
$0.4206
52주 변동 폭
$0.2179
$2.17
프로페이즈 Stock (PRPH) Company Profile
명칭
Prophase Labs Inc
전화
(215) 345-0919
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.2913 | 13.51M | 7.33M | -21.20M | -12.68M | -0.9143 |
|
TMO
Thermo Fisher Scientific Inc
|
564.83 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.75 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
720.38 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.88 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
212.27 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
프로페이즈 Stock (PRPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-13 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-01-20 | 개시 | Dawson James | Buy |
프로페이즈 주식(PRPH)의 최신 뉴스
Can machine learning forecast ProPhase Labs Inc. recoveryJuly 2025 Big Picture & Safe Entry Point Identification - newser.com
What moving averages say about ProPhase Labs Inc.CEO Change & AI Driven Price Predictions - newser.com
Is ProPhase Labs Inc. stock poised for growth2025 Major Catalysts & High Conviction Trade Alerts - newser.com
ProPhase Labs Inc. stock chart pattern explainedWeekly Profit Analysis & High Yield Stock Recommendations - newser.com
How ProPhase Labs Inc. stock reacts to job market dataJuly 2025 Review & Technical Buy Zone Confirmation - newser.com
Why analysts upgrade ProPhase Labs Inc. stockGDP Growth & Step-by-Step Trade Execution Guides - newser.com
Using data tools to time your ProPhase Labs Inc. exit2025 Market Sentiment & Expert Verified Movement Alerts - newser.com
What data driven models say about ProPhase Labs Inc.’s futurePortfolio Performance Summary & Weekly Market Pulse Alerts - newser.com
ProPhase Labs Inc. stock retracement – recovery analysisTrade Risk Summary & Long-Term Capital Growth Ideas - newser.com
Can ProPhase Labs Inc. stock beat analyst upgradesMarket Risk Analysis & Fast Moving Trade Plans - newser.com
Using data filters to optimize entry into ProPhase Labs Inc.Weekly Trend Report & AI Driven Stock Price Forecasts - newser.com
How strong is ProPhase Labs Inc. stock revenue growth2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
PRPH proxy: digital‑asset charter, tokenized equity cap, split range - Stock Titan
How hedge fund analytics apply to ProPhase Labs Inc. stockSwing Trade & Reliable Volume Spike Alerts - newser.com
Is ProPhase Labs Inc. building a consolidation baseWeekly Risk Summary & High Accuracy Buy Signal Tips - newser.com
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology - The Manila Times
ProPhase (NASDAQ: PRPH) BE-Smart study shows 100% sensitivity; AUC 0.89 - Stock Titan
ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measures - MSN
What technical signals suggest for ProPhase Labs Inc. stockJuly 2025 Price Swings & Safe Capital Investment Plans - fcp.pa.gov.br
ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts - The Manila Times
ProPhase Labs (NASDAQ: PRPH) engages RedChip to lead investor relations: $50M target - Stock Titan
How ProPhase Labs Inc. stock reacts to inflationary pressures2025 Top Decliners & Low Risk Profit Maximizing Plans - Fundação Cultural do Pará
프로페이즈 (PRPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
6.21%
자본화:
|
볼륨(24시간):